Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH opened at $0.06 on Monday. Bellerophon Therapeutics has a fifty-two week low of $0.03 and […]
Stock analysts at StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of BLPH stock opened at $0.06 on Monday. Bellerophon Therapeutics has a fifty-two week […]
StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of BLPH stock opened at $0.06 on Friday. The firm has a 50 day moving average price of $0.06 […]
Equities researchers at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of BLPH opened at $0.06 on Friday. The firm has a market capitalization of $672,650.00, […]
Research analysts at StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance Shares of NASDAQ BLPH opened at $0.06 on Friday. The stock has a market capitalization of […]